Standalone Financial Results, Limited Review Report for September 30, 2016
Abbott India Ltd has informed BSE about : 1. Standalone Financial Results for the period ended September 30, 20162. Standalone Limited Review for the period ended September 30, 2016 Updates
Abbott India Ltd has submitted to BSE a copy of newspaper cuttings of the notice given to Shareholders, published in Business Standard and Loksatta, Mumbai editions on November 23, 2016, regarding the application to be made by the Company to Central Government in accordance with the requirements under Section 196 and Schedule V of the Companies Act, 2013, for seeking the approval for the appointment of Mr Ambati Venu as Managing Director of the Company... Board Meeting Intimation for Results & Closure of Trading Window
Abbott India Ltd has informed BSE that a Meeting of the Board of Directors of the Company is scheduled to be held on November 28, 2016, inter alia, to consider and approve the text of Unaudited Financial Results of the Company for the half year ended on September 30, 2016.Further, in terms of Abbott India Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the Trading Window of the Company... Shareholding for the Period Ended September 30, 2016
Abbott India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly Click here Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016
Abbott India Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Abbott appoints new MD
Abbott India has appointed Ambati Venu as Managing Director, the multinational said after its board meeting today. The announcement comes almost five months after its previous MD Rehan Khan... Appointment of Managing Director
Abbott India Ltd has informed BSE that the Board at its Meeting held on September 29, 2016 approved the appointment of Mr Ambati Venu as the Additional Director on the Board and as the Managing Director of the Company for a term of 5 (five) years effective September 29, 2016, subject to approval from the Central Government and the Shareholders of the Company.Mr. Ambati does not hold any shares in the Company and also not related to any of the Board Directors of the Company. Abbott India Q1 net up 10% at Rs 74 crore
Shares of Abbott India on Friday closed at Rs 4,731.45 on BSE, up 0.62 per cent from the previous close Standalone Financial Results, Limited Review Report for June 30, 2016
Abbott India Ltd has informed BSE about : 1. Standalone Financial Results for the period ended June 30, 20162. Standalone Limited Review for the period ended June 30, 2016 Board Meeting Intimation for Results & Closure of Trading Window
Abbott India Ltd has informed BSE that a Meeting of the Board of Directors of the Company is scheduled to be held on August 26, 2016 inter alia, to consider and approve the text of Unaudited Financial Results of the Company for the first quarter ended on June 30, 2016.Further, in terms of Abbott India Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the Trading Window of the Company...